Home > What we do > Medicine & Healthcare > hMedicine > hMedicine Story

Hadassah Motivates Israel’s Government to Campaign for Women’s Heart Health

Left to right: MK Aliza Lavie, Chair, Committee for the Status of Women and General Equality; Yael German, Minister of Health; Dahlia Itzik, former Speaker of the Knesset; Dr. Donna Zfat-Zwas, Director of the Linda Joy Pollin Cardiovascular Wellness Center

Thanks to advocacy by the Hadassah Medical Center's Linda Joy Pollin Cardiovascular Wellness Center, women's heart health took center stage in Israel's Knesset, with a special hearing in its Committee for the Status of Women and General Equality.

Following a compelling session in which experts and patients spoke passionately about the need for raising awareness about women's heart health, Committee Chair MK Aliza Lavie charged the Ministry of Health to create a coalition immediately to advance awareness of women's unique heart issues, both among women, as well as health care givers. "In the United States, since the "Go Red" initiative for women's heart health in 1997," related Dr. Donna Zfat-Zwas, Director of Hadassah's Pollin Center, "the numbers of women dying from heart attacks has fallen. We are thrilled that the Knesset has demanded a nationwide campaign from the Ministry of Health.

"We have to investigate why more women die of their heart attacks than men," continued Dr. Zfat-Zwas, "but we're speculating that women who have heart attacks have more hypertension, more diabetes, and more kidney problems than men who are admitted with heart disease."

Representing Haredi women, who are at higher risk for heart attack than other groups, Rachel Thaler of Jerusalem described how she ignored chest pain for months before having a full-scale heart attack. "If women in the general sector are not aware of the risks of heart disease," she brought out, "this is even more so among women in my sector, who have large families and are the main breadwinners." The Pollin Center has initiated community outreach programs in Haredi neighborhoods, as well as Arab localities, since Arab women are also at higher risk. Click to read more about the Pollin Center.

 

Date: 3/10/2014

Hadassah’s Advanced Gene Sequencing Changes the Life of a Family from Uzbekistan

IDF Medic Heroically Battles Terrorist, Both Treated at Hadassah

Orthopedic Trauma Turns Tragedy into Innovation at Hadassah

On the Cutting-Edge of Melanoma Treatment: Hadassah’s Protocols and Research

Saving a Newborn from a Life Without Sight

Terrorist and Victim Sent to Hadassah's Hospitals After Third Attack in Two Weeks

Three Sent to Hadassah After Second Jerusalem Terror Attack of the Week

Clinical Trial of Hadassah-Developed Stem Cell Treatment for Macular Degeneration Gets Go-Ahead from FDA

“We Don’t Say ‘No’,” Hadassah Neurosurgeon Explains in Operating on 82-Year-Old Patient

Cutting-Edge Medicine and Research; a Role Model for Peace: A Briefing from the Hospital's Director General

4 Ways Hadassah Hospital is Preparing for Ebola—Just in Case

Hailing from 17 Countries: the 39th Graduation Class of Hadassah’s International Master of Public Health Program

At Hadassah, Four Recover, Two Tragically Perish After Light Rail Attack

Other Doctors Suggested Aborting the Baby. The Experts at Hadassah Knew Better.

Hadassah Doctor Receives International Prize for Medical Innovation

Hadassah Doctors Rescue Frostbitten Nepal Avalanche Victim

Thousands Mourn Loss of Young Israeli Hero

A Mysterious Case Sends a Family Searching for Cures, Finding Hadassah

Grateful Patients, Their Families, and Their Doctors Offer Thanks

Head of Hadassah's Hospital Addresses The Economist Health Care Forum



More hMedicine Stories




Hadasit, Hadassah’s Technology Transfer Arm, Reviews 2012’s Accomplishments

When the Hadassah University Medical Center’s physicians suggest a solution to a medical problem which can lead to the development of a new medicine or product, Hadasit, Hadassah’s technology transfer arm, explores its feasibility and supports the promotion of those viable ideas with innovation potential. Although 2012 has been “a year full of challenges for the life science industry,” says Einat Zisman, Hadasit’s Chief Executive Officer, Hadasit still signed 125 agreements for clinical trials, all to be done at Hadassah. In addition, Hadasit signed 15 agreements for cooperation and commercialization of technologies that were developed at Hadassah. Click here to read the latest Newsletter from Hadasit >>

   |  Who We Are  |  What We Do  |  Where We Do It  |  Read About It  |  Join Now  |  Donate  |
  |  Login  |  Contact Us  |  Careers  |  Terms & Conditions  |  
Copyright ©2014 Hadassah is a registered trademark of Hadassah, the Women's Zionist Organization of America